Skip to main content
. 2020 Jul 10;2020(7):CD013600. doi: 10.1002/14651858.CD013600.pub2
'Risk of bias' assessment of Jin 2020
Domain Assessed outcomes Authors' judgement Support for judgement
Representative study group (selection bias) Not available High 6 of 146 COVID‐19 patients in Guizhou Jiangjunshan Hospital who received convalescent plasma therapy included in report
Outcome detectors blinded to intervention (detection bias) Adverse events High Not blinded, awareness of intervention can bias assessment of subjective outcomes
Complete outcome assessment/follow‐up (attrition bias) Adverse events
  Unclear
  Assessed for all participants over study period, observation period unclear
 
Well‐defined study group (reporting bias) Not available Unclear Study population well described, but intervention scarcely described
Well‐defined outcome (reporting bias) Adverse events High Reported for all participants, but observation period unclear
Well‐defined risk estimates (analyses) Adverse events Not applicable No analyses performed
Important prognostic factors or follow‐up taken adequately into account (confounding)  Not available High Not adjusted for confounding, results only reported for 6 of 146 participants receiving convalescent plasma